NDC 68462-477-20 - Vancomycin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68462-477
- Requested NDC
- 68462-477-20
- Package NDCs from labels
- 68462-477-20, 68462-477-74
- Manufacturer
- GLENMARK PHARMACEUTICALS INC., USA | GLAND PHARMA LIMITED
- Effective date
- 2025-12-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VANCOMYCIN - GLENMARK PHARMACEUTICALS INC., USA | GLAND PHARMA LIMITED | GLENMARK PHARMACEUTICALS INC., USA | GLAND PHARMA LIMITED | 2025-12-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68462-477-20 | Vancomycin Hydrochloride | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 3 | |
| 68462-477-74 | Vancomycin Hydrochloride | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68462-477-20 | EA - Each | 68462-477 | b9e1db5b-b8c6-4eb8-8da5-addcd2827a92 | 1 | 2025-05-14 |
| 68462-477-74 | EA - Each | 68462-477 | a62f10f2-644c-4246-af5d-87e31404f252 | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | f2901045-904f-47bd-74a1-c561facd7f25 | 2026-04-01 | Warnings, Adverse reactions | 2049890 1807518 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | c9ea31ec-4c26-452f-b07b-c5f894212cd5 | 2026-04-01 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | ae6efaaf-37eb-4510-ba71-5f3dc3abdbd3 | 2026-03-31 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Plano Pharmaceuticals Inc. | 4983e3c8-e0f2-b366-e063-6394a90a9557 | 2026-03-25 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | 27d06545-1af0-4dcd-926d-58d4a9492ec3 | 2026-03-02 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | 3707ad2e-5c82-4111-a370-e518e5e7e4c5 | 2026-03-02 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Plano Pharmaceuticals Inc. | 4983f60c-0f7b-d427-e063-6394a90a838c | 2026-02-24 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ab658fbd-68ea-4275-84b1-c3361c860bd3 | 2026-02-11 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Gland Pharma Limited | 00946db3-d6c5-4534-a870-1ec6e63eda43 | 2026-01-30 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | XGen Pharmaceuticals DJB, Inc. | 4239165c-4c15-b78e-e063-6294a90ae6af | 2025-12-31 | Warnings, Adverse reactions | 2049890 2049888 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | GLENMARK PHARMACEUTICALS INC., USA | 0543b2b5-b1c7-4ad6-b38c-3be0086f0e06 | 2025-12-23 | Warnings, Adverse reactions | ANDA218140 68462-478-84 68462-479-84 68462-478-30 68462-477-74 68462-479-30 68462-477-20 68462-477 68462-478 68462-479 68462047720 2049890 1807518 2049888 210eb04c-a542-44da-b4a3-7e243186b483 0543b2b5-b1c7-4ad6-b38c-3be0086f0e06 71WO621TJD |
| Vancocin | VANCOMYCIN HYDROCHLORIDE | ANI Pharmaceuticals, Inc. | a078d9c2-f89c-4f9f-8ded-60ffb2983c3f | 2025-12-22 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Redpharm Drug | 3745b502-c222-e307-e063-6394a90a697e | 2025-12-18 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Strides Pharma Science Limited | fac438bd-e08f-438d-ab64-426fc5c5450e | 2025-11-28 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Henry Schein, Inc. | 1bda7fa4-fdee-410a-a216-02cfbf91632f | 2025-11-07 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | STERISCIENCE SPECIALTIES PRIVATE LIMITED | 2c355037-6a1e-4846-872a-471ccbdc8d54 | 2025-10-31 | Warnings, Adverse reactions | 2049890 1807518 2049888 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Civica, Inc | 50e4fb19-f603-439c-b193-25a455115383 | 2025-10-13 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC. | 8eccafe8-40c9-495a-872d-7f45a98ee759 | 2025-08-13 | Warnings, Adverse reactions | 2049890 1807518 2049888 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Sagent Pharmaceuticals | f623889c-a47a-4b3a-b3a9-e04051f5c2df | 2025-05-28 | Warnings, Adverse reactions | ANDA218140 2049890 1807518 2049888 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Fresenius Kabi USA, LLC | f604d399-fded-4f4f-8efe-af558ed07b9d | 2025-05-15 | Warnings, Adverse reactions | 1807518 71WO621TJD |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.